This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Shockwave Medical (SWAV) in Q3 Earnings?
by Zacks Equity Research
Shockwave Medical's (SWAV) third-quarter results are likely to reflect solid performance of its IVL system across geographies.
National Vision (EYE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
National Vision (EYE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What Awaits Lantheus Holdings (LNTH) This Earnings Season?
by Zacks Equity Research
Lantheus Holdings' (LNTH) third-quarter results are likely to reflect solid top line results on the back of robust product adoption.
AMN Healthcare (AMN) to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
AMN Healthcare's (AMN) third-quarter results are likely to reflect solid demand across all its segments.
Why National Vision (EYE) Could Beat Earnings Estimates Again
by Zacks Equity Research
National Vision (EYE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Alcon (ALC) Clareon Suite to Get a Boost With Product Launch
by Zacks Equity Research
With the latest launch of Clareon Toric, Alcon's (ALC) Clareon Collection of IOLs is complete in the United States.
National Vision (EYE) Q2 Earnings Top Mark, Revenue View Cut
by Zacks Equity Research
National Vision (EYE) is simultaneously facing demand headwinds across its network of stores, given the current macro environment, as well as supply challenges.
Company News for Aug 12, 2022
by Zacks Equity Research
Companies in The News Are: HBI,DDS,SIX,EYE
National Vision (EYE) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
National Vision (EYE) delivered earnings and revenue surprises of 162.50% and 1.25%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Why National Vision (EYE) Might Surprise This Earnings Season
by Zacks Equity Research
National Vision (EYE) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Verano Holdings Corp. (VRNOF) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Verano Holdings Corp. (VRNOF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Is VAALCO (EGY) Poised for a Robust Q2 Earnings Performance?
by Zacks Equity Research
While higher oil prices are likely to have boosted VAALCO Energy's (EGY) profit levels in the second quarter, escalation in costs might have played spoilsport.
National Vision (EYE) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
National Vision (EYE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Can Higher Margins Boost HF Sinclair (DINO) Q2 Earnings?
by Zacks Equity Research
While higher refining margins and throughput are likely to have boosted HF Sinclair's (DINO) profit levels in the second quarter, escalation in costs might have played spoilsport.
NanoString (NSTG) Surges 5.1%: Is This an Indication of Further Gains?
by Zacks Equity Research
NanoString (NSTG) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
National Vision (EYE) Gains on Volume Growth Amid Margin Woes
by Zacks Equity Research
National Vision (EYE) plans to continue executing its core growth initiatives and further investing in strengthening competitive advantages.
Here's Why You Should Retain National Vision (EYE) For Now
by Zacks Equity Research
Investors are optimistic about National Vision's (EYE) better-than-expected earnings and new store growth.
National Vision (EYE) Up 21.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
National Vision (EYE) Tops Q1 Earnings Estimates, Cuts '22 View
by Zacks Equity Research
National Vision (EYE) reports better-than-expected earnings and an increase in store count for the first quarter.
National Vision (EYE) Q1 Earnings Top Estimates
by Zacks Equity Research
National Vision (EYE) delivered earnings and revenue surprises of 22.22% and 4.07%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Owens & Minor (OMI) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 24.68% and 3.55%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
National Vision (EYE) Up 23.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
National Vision (EYE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
National Vision (EYE) Hurt by Rising Costs, Vendor Dependency
by Zacks Equity Research
High dependence on a limited number of suppliers exposes National Vision (EYE) to supplier concentration risk.
National Vision (EYE) Q4 Earnings Top Estimates, Margins Down
by Zacks Equity Research
Strength in America's Best and Eyeglass World brands drove National Vision's (EYE) performance in the fourth quarter of 2021.
National Vision (EYE) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
National Vision (EYE) delivered earnings and revenue surprises of 750% and 4.43%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?